文献速递外周动脉疾病

斯里兰卡科伦坡大学下肢静脉旁路治疗慢性肢体威胁性缺血的临床结局

Clinical Outcomes Following Lower Extremity Vein Bypass for Chronic Limb Threatening Ischaemia (CLTI) at the University of Colombo, Sri Lanka.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2020-08-07

研究纳入2015至2017年科伦坡大学367例符合SVS-OPG标准的下肢旁路患者,其糖尿病与组织缺损比例高于SVS和NSQIP队列。30天MALE为7.6%,与SVS和NSQIP无显著差异;30天MACE为8.2%,显著高于NSQIP但非SVS。12个月总生存82%在OPG阈值内,保肢81.8%和无截肢生存64.5%略超阈值。结论认为资源有限环境下静脉旁路优先策略可行有效。

要点

  • 科伦坡队列糖尿病80%、组织缺损100%,病情重于高收入国家队列。
  • 30天MALE 7.6%,与SVS和NSQIP无统计学显著差异。
  • 12个月总生存82%达标,保肢81.8%和无截肢生存64.5%略超OPG阈值。

核心结论

  • 静脉旁路治疗缺血性坏死在科伦坡大学结局可接受,与高收入国家相近,尽管肢体威胁更重且资源有限。
  • 数据提示静脉旁路优先策略在资源有限环境下治疗晚期缺血性坏死可行有效。

研究设计与样本

  • 单中心连续病例研究,纳入2015至2017年367例符合SVS-OPG标准的下肢旁路患者。
  • 报告30天MACE、MALE、死亡和截肢,以及1年总生存、保肢和无截肢生存。
  • 与SVS-OPG和NSQIP的历史队列进行比较。

主要发现

  • 糖尿病患病率80%,高于SVS的57%和NSQIP的50%(p < .001)。
  • 组织缺损比例100%,高于SVS的74%和NSQIP的59%(p < .001)。
  • 30天MALE为7.6%,与SVS的6.1%和NSQIP的9%无统计学显著差异。
  • 30天MACE为8.2%,显著高于NSQIP的4.2%(p < .001),与SVS的6.2%无显著差异(p = .20)。
  • 12个月总生存82%在OPG阈值内,保肢81.8%和无截肢生存64.5%略超阈值。

临床怎么用

  • 在资源有限环境下,对晚期缺血性坏死患者可考虑静脉旁路优先策略。
  • 需结合本地病情严重程度解读与高收入国家队列的比较数据。

局限性

  • 缺乏高质量流行病学数据,且为单中心研究。
  • 与SVS-OPG和NSQIP的比较基于历史队列,非随机对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although high quality epidemiological data are lacking, the global increase in chronic limb threatening ischaemia may be disproportionately affecting low and LMICs. All available data for outcomes from bypass for limb salvage are from high income countries, with none from LMIC settings where the challenge is greatest. This study aimed to assess the clinical outcomes following vein lower extremity bypass for chronic limb threatening ischaemia at the University of Colombo, Sri Lanka, and to compare patients and outcomes with those described in the Society for Vascular Surgery (SVS) Objective Performance Goals (OPG) and United States National Surgical Quality Improvement Program (NSQIP). METHODS: Consecutive patients (n = 367) undergoing SVS-OPG eligible lower extremity bypass between 2015 and 2017 were studied. Thirty day major adverse cardiovascular events (MACE), major adverse limb events (MALE), deaths, and amputations are reported, along with one year overall survival, limb salvage, and amputation free survival. RESULTS: Patients at University of Colombo had more diabetes mellitus (80% vs. SVS 57% vs. NSQIP 50%, p < .001) and tissue loss (100% vs. SVS 74% vs. NSQIP 59%, p < .001). The 30 day MALE was 7.6%, which is not a statistically significant difference from the SVS (6.1%) or NSQIP (9%). The 30 day MACE was 8.2%, statistically significantly higher than NSQIP (4.2%, p < .001) but not SVS (6.2%, p = .20). At 12 months, the overall survival (82%) was within the OPG threshold, but limb salvage (81.8%) and amputation free survival (64.5%) were just outside. CONCLUSION: Outcomes following vein bypass for ischaemic necrosis at the University of Colombo, Sri Lanka, are acceptable and similar to those reported from high income countries despite greater limb threat severity and resource limitations. Further real world data from similar settings on outcomes following revascularisation are required. These data suggest that a vein bypass first strategy for advanced ischaemic necrosis is feasible and effective even in resource limited settings.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Wijeyaratne M, Cassim R, Bradbury A, et al. Clinical Outcomes Following Lower Extremity Vein Bypass for Chronic Limb Threatening Ischaemia (CLTI) at the University of Colombo, Sri Lanka. Eur J Vasc Endovasc Surg. 2020. PMID: 32778492. doi:10.1016/j.ejvs.2020.06.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。